Catherine Curran

1.5k total citations
38 papers, 1.2k citations indexed

About

Catherine Curran is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Catherine Curran has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Catherine Curran's work include Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (7 papers) and MicroRNA in disease regulation (5 papers). Catherine Curran is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (7 papers) and MicroRNA in disease regulation (5 papers). Catherine Curran collaborates with scholars based in Ireland, United States and United Kingdom. Catherine Curran's co-authors include Michael J. Kerin, Nicola Miller, Róisín M. Dwyer, E. Hennessy, John Newell, Elrasheid A. H. Kheirelseid, Sonja Khan, Karl Sweeney, Fiachra Martin and Mary Murphy and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Catherine Curran

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Curran Ireland 18 592 514 505 169 138 38 1.2k
Craig P. Giacomini United States 16 510 0.9× 780 1.5× 417 0.8× 177 1.0× 61 0.4× 18 1.3k
JS Reis‐Filho United Kingdom 10 409 0.7× 412 0.8× 377 0.7× 251 1.5× 45 0.3× 22 897
Bastien Job France 13 426 0.7× 611 1.2× 314 0.6× 68 0.4× 190 1.4× 38 1.1k
Emma Tham Sweden 19 373 0.6× 470 0.9× 359 0.7× 211 1.2× 53 0.4× 59 1.2k
Carolina Vicente‐Dueñas Spain 18 244 0.4× 728 1.4× 495 1.0× 208 1.2× 110 0.8× 41 1.2k
Helen J. Huang United States 19 418 0.7× 689 1.3× 336 0.7× 256 1.5× 102 0.7× 47 1.3k
Sana Yokoi Japan 21 297 0.5× 870 1.7× 498 1.0× 87 0.5× 143 1.0× 43 1.4k
Trisha Dwight Australia 23 588 1.0× 514 1.0× 356 0.7× 101 0.6× 174 1.3× 42 1.6k
Ben Kinnersley United Kingdom 15 267 0.5× 465 0.9× 208 0.4× 284 1.7× 135 1.0× 26 902
Kathy Astrahantseff Germany 17 383 0.6× 645 1.3× 308 0.6× 43 0.3× 120 0.9× 36 1.2k

Countries citing papers authored by Catherine Curran

Since Specialization
Citations

This map shows the geographic impact of Catherine Curran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Curran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Curran more than expected).

Fields of papers citing papers by Catherine Curran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Curran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Curran. The network helps show where Catherine Curran may publish in the future.

Co-authorship network of co-authors of Catherine Curran

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Curran. A scholar is included among the top collaborators of Catherine Curran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Curran. Catherine Curran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curran, Catherine, et al.. (2025). Health differences between rural and non-rural Texas counties based on 2023 County Health Rankings. BMC Health Services Research. 25(1). 2–2. 2 indexed citations
2.
Yambasu, Sahr, Fiona Boland, Keelin O’Donoghue, et al.. (2025). Digital Foetal Scalp Stimulation Versus Foetal Blood Sampling to Assess Foetal Well‐Being in Labour: A Multicentre Randomised Controlled Trial. BJOG An International Journal of Obstetrics & Gynaecology. 132(5). 557–564.
3.
McVeigh, Terri, et al.. (2020). Diagnostic yield of a custom-designed multi-gene cancer panel in Irish patients with breast cancer. Irish Journal of Medical Science (1971 -). 189(3). 849–864. 1 indexed citations
4.
Lowery, Aoïfe, Catherine Curran, Ray McLaughlin, et al.. (2019). A Review of the Impact of Neoadjuvant Chemotherapy on Breast Surgery Practice and Outcomes. Clinical Breast Cancer. 19(5). 377–382. 22 indexed citations
5.
McAnena, Peter, Kahraman Tanrıverdi, Catherine Curran, et al.. (2019). Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer. BMC Cancer. 19(1). 436–436. 66 indexed citations
6.
Curran, Catherine, Mark Webber, Grace Callagy, et al.. (2019). Quantifying Tip60 (Kat5) stratifies breast cancer. Scientific Reports. 9(1). 3819–3819. 21 indexed citations
7.
Prakash, A, Emma Holian, Andrew McGuire, et al.. (2019). Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer. BMC Cancer. 19(1). 712–712. 28 indexed citations
8.
Joyce, Doireann, Ciarán O’Neill, Helen Heneghan, et al.. (2018). The changing cost of breast cancer care: lessons from a centralised modern cancer centre. Irish Journal of Medical Science (1971 -). 188(2). 409–414. 2 indexed citations
9.
Holian, Emma, Catherine Curran, Carmel Malone, et al.. (2017). Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab. Breast Cancer Research and Treatment. 164(1). 221–229. 8 indexed citations
10.
Khan, Sonja, Deirdre Wall, Catherine Curran, et al.. (2015). MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid. BMC Cancer. 15(1). 345–345. 50 indexed citations
11.
Kheirelseid, Elrasheid A. H., Nicola Miller, Kah Hoong Chang, et al.. (2012). miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy. International Journal of Colorectal Disease. 28(2). 247–260. 64 indexed citations
12.
Ryan, James, Catherine Curran, E. Hennessy, et al.. (2011). The Sodium Iodide Symporter (NIS) and Potential Regulators in Normal, Benign and Malignant Human Breast Tissue. PLoS ONE. 6(1). e16023–e16023. 27 indexed citations
13.
Potter, Shirley, et al.. (2011). Influence of stromal–epithelial interactions on breast cancer in vitro and in vivo. Breast Cancer Research and Treatment. 131(2). 401–411. 24 indexed citations
14.
Dwyer, Róisín M., Maria Costello, Catherine Curran, et al.. (2011). Relationship between CCL5 and transforming growth factor-β1 (TGFβ1) in breast cancer. European Journal of Cancer. 47(11). 1669–1675. 22 indexed citations
15.
Chang, Kah Hoong, Nicola Miller, Elrasheid A. H. Kheirelseid, et al.. (2011). MicroRNA-21 and PDCD4 expression in colorectal cancer. European Journal of Surgical Oncology. 37(7). 597–603. 60 indexed citations
16.
Glynn, Ronan W., Sarah Mahon, Catherine Curran, et al.. (2011). TOP2A Amplification in the Absence of That of HER-2/neu: Toward Individualization of Chemotherapeutic Practice in Breast Cancer. The Oncologist. 16(7). 949–955. 9 indexed citations
17.
Kheirelseid, Elrasheid A. H., Nicola Miller, Catherine Curran, et al.. (2010). Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. Breast Cancer Research and Treatment. 126(1). 131–140. 105 indexed citations
18.
Martin, Fiachra, Róisín M. Dwyer, John Kelly, et al.. (2010). Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Research and Treatment. 124(2). 317–326. 247 indexed citations
19.
Colleran, Gabrielle, Niall McInerney, Andrew Rowan, et al.. (2009). The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer. Breast Cancer Research and Treatment. 119(2). 437–442. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026